These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25249229)

  • 1. Effects of severity of dementia on a symptom validity measure.
    Walter J; Morris J; Swier-Vosnos A; Pliskin N
    Clin Neuropsychol; 2014; 28(7):1197-208. PubMed ID: 25249229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance and Symptom Validity Assessment in Patients with Apathy and Cognitive Impairment.
    Dandachi-FitzGerald B; Duits AA; Leentjens AFG; Verhey FRJ; Ponds RWHM
    J Int Neuropsychol Soc; 2020 Mar; 26(3):314-321. PubMed ID: 31658930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Test of Memory Malingering (TOMM): normative data from cognitively intact, cognitively impaired, and elderly patients with dementia.
    Teichner G; Wagner MT
    Arch Clin Neuropsychol; 2004 Apr; 19(3):455-64. PubMed ID: 15033228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Visual Association Test-Extended: a cross-sectional study of the performance validity measures.
    Meyer SR; de Jonghe JF; Schmand B; Ponds RW
    Clin Neuropsychol; 2017 May; 31(4):798-813. PubMed ID: 28156190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the limits of effort testing: symptom validity tests and severity of neurocognitive symptoms in nonlitigant patients.
    Merten T; Bossink L; Schmand B
    J Clin Exp Neuropsychol; 2007 Apr; 29(3):308-18. PubMed ID: 17454351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short Montreal Cognitive Assessment.
    Larner AJ
    J Geriatr Psychiatry Neurol; 2017 Mar; 30(2):104-108. PubMed ID: 28013571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptom validity testing in memory clinics: Hippocampal-memory associations and relevance for diagnosing mild cognitive impairment.
    Rienstra A; Groot PF; Spaan PE; Majoie CB; Nederveen AJ; Walstra GJ; de Jonghe JF; van Gool WA; Olabarriaga SD; Korkhov VV; Schmand B
    J Clin Exp Neuropsychol; 2013; 35(1):59-70. PubMed ID: 23228141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the repeatable battery for the assessment of neuropsychological status effort scale and effort index in a dementia sample.
    Dunham KJ; Shadi S; Sofko CA; Denney RL; Calloway J
    Arch Clin Neuropsychol; 2014 Nov; 29(7):633-41. PubMed ID: 25236719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of Montreal Cognitive Assessment and Discriminant Power of Montreal Cognitive Assessment Subtests in Patients With Mild Cognitive Impairment and Alzheimer Dementia in Turkish Population.
    Kaya Y; Aki OE; Can UA; Derle E; Kibaroğlu S; Barak A
    J Geriatr Psychiatry Neurol; 2014 Jun; 27(2):103-9. PubMed ID: 24578463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How valid are subjective ratings of prospective memory in mild cognitive impairment and early dementia?
    Thompson CL; Henry JD; Rendell PG; Withall A; Brodaty H
    Gerontology; 2015; 61(3):251-7. PubMed ID: 25792282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The repeatable battery for the assessment of the neuropsychological status (RBANS): a diagnostic validity study in Greek elderly.
    Tsatali M; Fotiadou F; Giaglis G; Tsolaki M
    Aging Clin Exp Res; 2019 Sep; 31(9):1305-1312. PubMed ID: 30471005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimizing evaluation time while maintaining accuracy: Cross-validation of the Test of Memory Malingering (TOMM) Trial 1 and first 10-item errors as briefer performance validity tests.
    Kraemer LDR; Soble JR; Phillips JI; Webber TA; Fullen CT; Highsmith JM; Alverson WA; Critchfield EA
    Psychol Assess; 2020 May; 32(5):442-450. PubMed ID: 32027161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between the Test of Memory Malingering (TOMM) and the Nonverbal Medical Symptom Validity Test (NV-MSVT) in adults with disability claims.
    Green P
    Appl Neuropsychol; 2011 Jan; 18(1):18-26. PubMed ID: 21390896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Albany Consistency Index for the Test of Memory Malingering.
    Gunner JH; Miele AS; Lynch JK; McCaffrey RJ
    Arch Clin Neuropsychol; 2012 Jan; 27(1):1-9. PubMed ID: 22107827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance on the test of memory malingering (TOMM) among a large clinic-referred pediatric sample.
    Kirk JW; Harris B; Hutaff-Lee CF; Koelemay SW; Dinkins JP; Kirkwood MW
    Child Neuropsychol; 2011; 17(3):242-54. PubMed ID: 21294004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Utility in detection and characterization of mild cognitive impairment due to Alzheimer's disease.
    Karantzoulis S; Novitski J; Gold M; Randolph C
    Arch Clin Neuropsychol; 2013 Dec; 28(8):837-44. PubMed ID: 23867976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptom validity test performance in the Huntington Disease Clinic.
    Sieck BC; Smith MM; Duff K; Paulsen JS; Beglinger LJ
    Arch Clin Neuropsychol; 2013 Mar; 28(2):135-43. PubMed ID: 23266566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing sub-optimal performance with the Test of Memory Malingering in Spanish speaking patients with TBI.
    Strutt AM; Scott BM; Lozano VJ; Tieu PG; Peery S
    Brain Inj; 2012; 26(6):853-63. PubMed ID: 22583176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effort testing in schizophrenia and schizoaffective disorder: validity indicator profile and test of memory malingering performance characteristics.
    Hunt S; Root JC; Bascetta BL
    Arch Clin Neuropsychol; 2014 Mar; 29(2):164-72. PubMed ID: 24002172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of the Rey 15-Item Test, recognition trial, and error scores for detecting noncredible neuropsychological performance in a mixed clinical sample of veterans.
    Bailey KC; Soble JR; O'Rourke JJF
    Clin Neuropsychol; 2018 Jan; 32(1):119-131. PubMed ID: 28555516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.